Search

Your search keyword '"Diego Ottaviani"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Diego Ottaviani" Remove constraint Author: "Diego Ottaviani"
39 results on '"Diego Ottaviani"'

Search Results

1. Metabolic-imaging of human glioblastoma live tumors: A new precision-medicine approach to predict tumor treatment response early

2. COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry

Catalog

Books, media, physical & digital resources

3. Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective

4. Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score

5. Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience

6. Supplementary Data from Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer

7. Data from Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer

8. Survival Outcomes and Prognostic Factors in Glioblastoma

9. Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

10. Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

11. Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital

12. Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry

13. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

14. Abstract S01-03: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score

15. Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study

16. Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of patients with cancer who recovered from SARS-Cov-2 infection: results from the OnCovid registry

17. Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy

18. Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe

19. BIOM-26. SURVIVAL OUTCOMES AND PROGNOSTIC FACTORS IN PRIMARY GLIOBLASTOMA FROM A REAL-WORLD RETROSPECTIVE STUDY

20. Clinical portrait of the SARS-CoV-2 epidemic in european patients with cancer

21. Abstract 701: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score

22. Determinants of enhanced vulnerability to Covid-19 in U.K. cancer patients: Results from the OnCovid study

23. 319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection

24. Influence of antibiotic therapy (ATB) on oncological outcomes of metastatic non-small cell lung cancer (mNSCLC) patients treated with chemo-immunotherapy (CIT)

25. Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach

27. Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer

28. CTCF binds to sites in the major histocompatibility complex that are rapidly reconfigured in response to interferon-gamma

29. Angiogenic Functions of Voltage-gated Na+ Channels in Human Endothelial Cells

30. Antibiotic treatment prior to immune checkpoint inhibitor therapy as a tumor-agnostic predictive correlate of response in routine clinical practice

31. DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomas

32. MP16-06 ‘WHATSAPP DOC?' EVALUATING A NOVEL MODALITY OF COMMUNICATION AMONGST UROLOGY TEAM MEMBERS TO PROMOTE PATIENT SAFETY

33. ATIM-06. DOES THE OCCURRENCE OF A RASH CORRELATE WITH RESPONSE IN GLIOBLASTOMA PATIENTS TREATED WITH IPILIMUMAB?

34. BORIS/CTCFL is an RNA-binding protein that associates with polysomes

35. The role of microhomology in genomic structural variation

36. Angiogenic functions of voltage-gated Na+ Channels in human endothelial cells: modulation of vascular endothelial growth factor (VEGF) signaling

37. Reconfiguration of genomic anchors upon transcriptional activation of the human major histocompatibility complex

38. Generation of a genomic tiling array of the human Major Histocompatibility Complex (MHC) and its application for DNA methylation analysis

39. Anchoring the genome